Cargando…
Bioresorbable scaffolds for percutaneous coronary interventions
Innovations in drug-eluting stents (DES) have substantially reduced rates of in-segment restenosis and early stent thrombosis, improving clinical outcomes following percutaneous coronary interventions (PCI). However a fixed metallic implant in a vessel wall with restored patency and residual disease...
Autor principal: | Gogas, Bill D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355515/ https://www.ncbi.nlm.nih.gov/pubmed/25780795 http://dx.doi.org/10.5339/gcsp.2014.55 |
Ejemplares similares
-
Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention
por: Tenekecioglu, Erhan, et al.
Publicado: (2016) -
Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions
por: Felix, Cordula, et al.
Publicado: (2015) -
Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan
por: Gogas, Bill D., et al.
Publicado: (2015) -
Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions: 2017 revision
por: Everaert, B., et al.
Publicado: (2017) -
Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
por: Capodanno, Davide
Publicado: (2017)